THE MEDICAL CTR OF SOUTHEAST TEXAS — History
CCN 450518 | 3-year financial timeline | COVID resilience: 63/100
🛡️ Public data only — no PHI permitted on this instance.
$131M
Latest Revenue (FY2022)
+2.8%
Revenue CAGR (3yr)
-4.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $124M | $142M | $131M | -7.6% | +2.8% |
| Operating Expenses | $134M | $135M | $137M | +1.4% | +1.1% |
| Operating Margin | -7.6% | 5.2% | -4.1% | -178.9% | +0.0% |
| Net Income | $-9M | $7M | $-5M | -172.9% | +0.0% |
| Licensed Beds | 185 | 188 | 196 | +4.3% | +2.9% |
| Total Patient Days | 28,307 | 29,222 | 24,916 | -14.7% | -6.2% |
| Medicare Day % | 24% | 21% | 20% | -0.7% | -7.6% |
| Medicaid Day % | 11% | 6% | 10% | +61.7% | -3.7% |
COVID Impact & Recovery
Resilience Score: 63/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +5.7% ($124M → $131M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.8%
This Hospital
+7.6%
State Avg
Latest Margin
-4.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $135M | -2.3% |
| FY2024 (proj) | $138M | -0.5% |
| FY2025 (proj) | $142M | 1.3% |